AS
Anantharamaiah Sudeendra
About Anantharamaiah Sudeendra
Data last updated:
Anantharamaiah Sudeendra is a Managing Director at Ifimed Pharmaceuticals Private Limited (since 2012) and Designated Partner at Nectamed Laboratories Llp (since 2017). The companies operate in Pharma and Electrnoics. The largest current company by reported revenue is Ifimed Pharmaceuticals Private Limited at ₹6.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ifimed Pharmaceuticals Private Limited U51397KA2012PTC065239 | Managing Director | 09 Aug 2012 | 2012 | ₹6.26 Cr (FY 2025) | Active |
 Nectamed Laboratories Llp AAK-7131 | Designated Partner | 28 Sep 2017 | 2017 | Active |
Board colleagues of Anantharamaiah Sudeendra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prabhudev Pavithra | 05328985 | Ifimed Pharmaceuticals Private Limited | Director |
| Girish Basavaraju | 07921922 | Nectamed Laboratories Llp | Designated Partner |
| Thuraganur Mahadevu Manjunath | 07921937 | Nectamed Laboratories Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anantharamaiah Sudeendra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anantharamaiah Sudeendra
Anantharamaiah Sudeendra currently holds 2 directorships: Ifimed Pharmaceuticals Private Limited (Managing Director, since 09 Aug 2012, revenue ₹6.26 Cr (FY 2025)); Nectamed Laboratories Llp (Designated Partner, since 28 Sep 2017).
Anantharamaiah Sudeendra was first appointed on 09 Aug 2012 as Managing Director at Ifimed Pharmaceuticals Private Limited. The most recent appointment on record is 28 Sep 2017 at Nectamed Laboratories Llp.
The current boards of Anantharamaiah Sudeendra's companies include Prabhudev Pavithra (Ifimed Pharmaceuticals Private Limited), Girish Basavaraju (Nectamed Laboratories Llp), Thuraganur Mahadevu Manjunath (Nectamed Laboratories Llp).